Oral Contraceptives: Current Status
- 1 March 2001
- journal article
- review article
- Published by Wolters Kluwer Health in Clinical Obstetrics and Gynecology
- Vol. 44 (1), 62-72
- https://doi.org/10.1097/00003081-200103000-00010
Abstract
During the past four decades, oral contraceptives have remained a safe and effective method of birth control. Reductions in the estrogen and progestin dosages have significantly decreased the incidence of cardiovascular complications. The association between oral contraceptives and breast cancer appears to be primarily because of detection bias or possibly a promotional effect. Despite the changes in formulation, the problems related to side effects have not been totally solved. Because compliance and successful use is strongly affected by side effects, improvement in this area is probably the biggest challenge faced by developers of oral contraceptives. It is also clear that there are a growing number of significant noncontraceptive benefits that accrue in oral contraceptive users. Unfortunately, many women do not know about these benefits. Thus, one of the issues that providers need to continue to address is how to provide better information about oral contraceptives and contraception in general to patients.Keywords
This publication has 24 references indexed in Scilit:
- Risk of Breast Cancer With Oral Contraceptive Use in Women With a Family History of Breast CancerJAMA, 2000
- Consensus conference on combination oral contraceptives and cardiovascular diseaseFertility and Sterility, 1999
- The epidemiology of oral contraceptive use: A critical review of the studies on oral contraceptives and the health of young womenAmerican Journal of Obstetrics and Gynecology, 1998
- Blood Coagulation and Oral Contraceptives: A Critical ReviewContraception, 1998
- The use of oral contraceptives and the occurrence of acute myocardial infarction in young women: Results from the transnational study on oral contraceptives and the health of young womenContraception, 1997
- Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptomsObstetrics & Gynecology, 1997
- Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studiesThe Lancet, 1996
- Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutationThe Lancet, 1994
- A randomized, double-blind, placebo-controlled comparison of the impact of low-dose and triphasic oral contraceptives on follicular developmentAmerican Journal of Obstetrics and Gynecology, 1992
- Oral Contraceptive Estrogen Dose and the Risk of Deep Venous Thromboembolic DiseaseAmerican Journal of Epidemiology, 1991